Boris Peaker's Stock Ratings

TD Cowen Analyst

Boris Peaker is an analyst at TD Cowen. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/26/2024

Overall Average Return

98.9%

Smart Score

66.6%

Overall Average Return Percentile

98th

Number of Ratings

19
Buy NowGet Alert
07/26/2024GLYCBuy Now
GlycoMimetics
$0.24DowngradeBuy → HoldGet Alert
05/10/2024MGNXBuy Now
Macrogenics
$5.49DowngradeBuy → HoldGet Alert
04/16/2024ALPNBuy Now
Alpine Immune Sciences
DowngradeBuy → HoldGet Alert
04/09/2024MGNXBuy Now
Macrogenics
$5.49UpgradeHold → BuyGet Alert
12/04/2023LNTHBuy Now
Lantheus Holdings
$112.71-11.28% → $100Initiates → OutperformGet Alert
11/09/2023ADCTBuy Now
ADC Therapeutics
$3.52DowngradeOutperform → Market PerformGet Alert
08/03/2023PCRXBuy Now
Pacira BioSciences
$20.03149.63% → $50UpgradeMarket Perform → OutperformGet Alert
04/18/2023PCVXBuy Now
Vaxcyte
$84.05Initiates → OutperformGet Alert
04/17/2023CTICBuy Now
CTI BioPharma
$10 → $8MaintainsOutperformGet Alert
03/21/2023SGENBuy Now
Seagen
$145 → $129MaintainsMarket PerformGet Alert
12/06/2022XNCRBuy Now
Xencor
$21.60Initiates → OutperformGet Alert
11/22/2022MGNXBuy Now
Macrogenics
$5.49DowngradeOutperform → Market PerformGet Alert
09/12/2022EBSBuy Now
Emergent BioSolutions
$13.94108.03%$30 → $29MaintainsMarket PerformGet Alert
07/11/2022CTMXBuy Now
CytomX Therapeutics
$1.46DowngradeOutperform → Market PerformGet Alert
07/07/2022CTICBuy Now
CTI BioPharma
→ $10Initiates → OutperformGet Alert
06/27/2022MRKBuy Now
Merck & Co
$125.59-18.78%$95 → $102MaintainsMarket PerformGet Alert
03/15/2022NKTRBuy Now
Nektar Therapeutics
$1.38DowngradeOutperform → Market PerformGet Alert
03/03/2022NCNABuy Now
NuCana
$3.30DowngradeOutperform → Market PerformGet Alert
02/04/2022JNCEBuy Now
Jounce Therapeutics
UpgradeMarket Perform → OutperformGet Alert